Melanoma: all 3,073 studies
Page 16 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- ITIL-168 in Advanced MelanomaTerminatedNCT05050006Phase 2
- Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal MelanomaStatus unknownNCT05047276Phase 1/2
- PD-1 Antibody Therapy + Infliximab for Metastatic MelanomaActive, not recruitingNCT05034536Phase 2
- A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with CancersCompletedNCT05031494Phase 2
- Effects of Simulated Solar Radiation on Human Skin in Preventing Skin CancerCompletedNCT05027009Not applicable
- An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular MelanomaActive, not recruitingNCT05022901Phase 3
- MoleGazer Development Feasibility StudyActive, not recruitingNCT05015816Not applicable
- Axitinib + Ipilimumab in Advanced MelanomaActive, not recruitingNCT04996823Phase 2
- Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable MelanomaWithdrawnNCT04995094Phase 2
- Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint InhibitorsActive, not recruitingNCT04990726
- Nous-PEV: a Novel Immunotherapy for Lung Cancer and MelanomaTerminatedNCT04990479Phase 1
- Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOmaCompletedNCT04988841Phase 2
- GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer PatientsWithdrawnNCT04987996Phase 2
- Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of MelanomaStatus unknownNCT04979585Phase 2
- A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced MelanomaActive, not recruitingNCT04971499Phase 1/2
- Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic MelanomaTerminatedNCT04967196Phase 1
- Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.CompletedNCT04961619
- NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNtsCompletedNCT04960059
- A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and NivolumabWithdrawnNCT04955262Phase 1
- Fecal Microbial Transplantation Non-Small Cell Lung Cancer and MelanomaActive, not recruitingNCT04951583Phase 2
- Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III MelanomaActive, not recruitingNCT04949113Phase 3
- 7T MRI Scan for the Early Detection of Melanoma Brain MetastasesTerminatedNCT04941430Not applicable
- Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaActive, not recruitingNCT04940299Phase 2
- NeoVax + CDX-301 and Nivolumab or Pembrolizumab in MelanomaActive, not recruitingNCT04930783Phase 1
- SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORSStatus unknownNCT04929353Not applicable
- Evaluation of Cytokine Biomarkers in Melanoma Patients During ImmunotherapyStatus unknownNCT04928365Phase 2
- L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant MelanomaTerminatedNCT04924413Phase 2
- Search for New Predictive Markers of the Immune Response in Vitiligo and MelanomaCompletedNCT04920162Not applicable
- A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma PatientsCompletedNCT04911998
- Targeted Imaging of Melanoma for Alpha-Particle RadiotherapyCompletedNCT04904120Phase 1
- Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTIONTerminatedNCT04901988Phase 2/3
- Detection and Metabolic Characterization in DOPA PET/CT of Brain MetastasesCompletedNCT04890028Not applicable
- A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant MelanomaStatus unknownNCT04884997Phase 2
- FHD-286 in Subjects With Metastatic Uveal MelanomaTerminatedNCT04879017Phase 1
- Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial CarcinomaStatus unknownNCT04871334Phase 1
- The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)SuspendedNCT04866810Not applicable
- Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)Active, not recruitingNCT04866680Not applicable
- Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid TumorsStatus unknownNCT04860076
- Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic MelanomaStatus unknownNCT04849260Phase 1/2
- A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.Active, not recruitingNCT04835805Phase 1
- A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanomaTerminatedNCT04834973Phase 1/2
- Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6TerminatedNCT04830124Phase 2
- To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer TreatmentActive, not recruitingNCT04821570
- Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver MetastasesCompletedNCT04812470Phase 1
- A Study to Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced CancerTerminatedNCT04809805Phase 1
- Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsActive, not recruitingNCT04802876Phase 2
- Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic ManagementCompletedNCT04789421Not applicable
- A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid TumorsCompletedNCT04773951Phase 1
- A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesCompletedNCT04772989Phase 1
- First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ MalignanciesStatus unknownNCT04763083Phase 1
- RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and MelanomaTerminatedNCT04762225Phase 1
- Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.CompletedNCT04760080
- Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF MelanomaWithdrawnNCT04759846Phase 1
- MElanoma Research Lymph Node Prediction Implementation National_001Active, not recruitingNCT04759781
- AI Augmented Training for Skin SpecialistsCompletedNCT04758988Not applicable
- A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced MelanomaStatus unknownNCT04756934Phase 1
- 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
- A Study of HX008 for the Treatment of Patients With Malignant MelanomaStatus unknownNCT04749485Phase 2
- Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant MelanomaStatus unknownNCT04747561Not applicable
- Defining the Role of the Skin Microbiome in Immune-related Adverse EventsTerminatedNCT04734704Not applicable
- Family History App in Personalized MedicineCompletedNCT04726319Not applicable
- A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsTerminatedNCT04725331Phase 1/2
- Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable MelanomaActive, not recruitingNCT04722575Phase 2
- A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable MelanomaActive, not recruitingNCT04708418Phase 2
- Sargramostim (GM-CSF) + PD-1WithdrawnNCT04703426Phase 2
- Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous MelanomaTerminatedNCT04702854Not applicable
- Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)CompletedNCT04700072Phase 1/2
- Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence AlgorithmStatus unknownNCT04695015
- Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageTerminatedNCT04688749
- Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma PatientsCompletedNCT04680182Not applicable
- Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma SurvivorsCompletedNCT04675346
- Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced MelanomaActive, not recruitingNCT04674683Phase 3
- Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerCompletedNCT04670445Not applicable
- Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete ResectionActive, not recruitingNCT04666272
- Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic MelanomaTerminatedNCT04663126Early Phase 1
- A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaActive, not recruitingNCT04657991Phase 3
- A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With MelanomaTerminatedNCT04653038Phase 1
- Suction Drain in Axillary Lymph Node Dissection for Malignant MelanomaCompletedNCT04648163
- Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyActive, not recruitingNCT04645680Phase 2
- Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) MutationStatus unknownNCT04633902Phase 2
- Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.Status unknownNCT04625491
- A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced MelanomaTerminatedNCT04625205Phase 1
- Lenvatinib and Pembrolizumab in Resectable Mucosal MelanomaStatus unknownNCT04622566Phase 2
- In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsActive, not recruitingNCT04616248Phase 1
- War on Melanoma™ Public Health & Education CampaignActive, not recruitingNCT04611568Not applicable
- Brentuximab Vedotin With Pembrolizumab in Metastatic Solid TumorsCompletedNCT04609566Phase 2
- A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid TumorsActive, not recruitingNCT04606472Phase 1
- Melanoma Detection in Switzerland With VECTRACompletedNCT04605822
- TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyTerminatedNCT04596033Phase 1
- Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital TractStatus unknownNCT04593485Phase 2
- Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of MelanomaCompletedNCT04581382Early Phase 1
- Uveal Melanoma and Brachytheraphy: Long-term Outcomes.CompletedNCT04577742
- The IRMI-FMT TrialTerminatedNCT04577729Not applicable
- Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and MelanomaActive, not recruitingNCT04572451Phase 1
- Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint InhibitorsActive, not recruitingNCT04565769
- DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 YearsCompletedNCT04563949
- IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma PatientsActive, not recruitingNCT04562129Phase 2
- A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive MelanomasCompletedNCT04551352Phase 1
- A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in FranceActive, not recruitingNCT04550247
- Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy KitsCompletedNCT04550000